- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 1089-1103 of
1,371 results
2109 Exhibit: JSN 2109 Hotte and Saad, ¿¿¿Current management of castrate resista...
Document
IPR2016-01582, No. 2109-186 Exhibit - JSN 2109 Hotte and Saad, ¿¿¿Current management of castrate resistant prostate cancer,¿¿¿ Current Oncology, 172S72 S79 2010 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2089 Exhibit: JSN 2089 NCI SEER Stat Fact Sheets Prostate Cancer
Document
IPR2016-01582, No. 2089-168 Exhibit - JSN 2089 NCI SEER Stat Fact Sheets Prostate Cancer (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2080 Exhibit: JSN 2080 Antonarakis and Eisenberger, ¿¿¿Phase III Trials With Docet...
Document
IPR2016-01582, No. 2080-159 Exhibit - JSN 2080 Antonarakis and Eisenberger, ¿¿¿Phase III Trials With Docetaxel Based Combinations for Metastatic Castration Resistant Prostate Cancer Time ...
|
|
Cite Document
2035 Exhibit: JSN 2035 Press Release 1202015
Document
IPR2016-01582, No. 2035-115 Exhibit - JSN 2035 Press Release 1202015 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2046 Exhibit: JSN 2046 Therasse et al, ¿¿¿New Guidelines to Evaluate the Response...
Document
IPR2016-01582, No. 2046-125 Exhibit - JSN 2046 Therasse et al, ¿¿¿New Guidelines to Evaluate the Response to Treatment in Solid Tumors,¿¿¿ J Natl Cancer Inst, 92205 216 2000 (P.T.A.B. Mar. ...
|
|
Cite Document
1063 Exhibit: Jevtana Website
Document
IPR2016-01582, No. 1063-62 Exhibit - Jevtana Website (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2082 Exhibit: JSN 2082 Mulcahy, Medscape October 17, 2008 Press Release
Document
IPR2016-01582, No. 2082-161 Exhibit - JSN 2082 Mulcahy, Medscape October 17, 2008 Press Release (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1070 Exhibit: Cowen Company July 2, 2012
Document
IPR2016-01582, No. 1070-69 Exhibit - Cowen Company July 2, 2012 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1033 Exhibit: Review of Medical Physiology 1979
Document
IPR2016-01582, No. 1033-32 Exhibit - Review of Medical Physiology 1979 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1126 Exhibit: Replacement of WCK1090
Document
IPR2016-01582, No. 1126-289 Exhibit - Replacement of WCK1090 (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1123 Exhibit: Supplemental Declaration of Declaration of Paul A Godley, MD, PhD, ...
Document
IPR2016-01582, No. 1123-286 Exhibit - Supplemental Declaration of Declaration of Paul A Godley, MD, PhD, MPP (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1064 Exhibit: FDA News Release June 17, 2010
Document
IPR2016-01582, No. 1064-63 Exhibit - FDA News Release June 17, 2010 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2023 Exhibit: JSN 2023 Herr and Pfitzenmaier, ¿¿¿Glucocorticoid use in prostate can...
Document
IPR2016-01582, No. 2023-104 Exhibit - JSN 2023 Herr and Pfitzenmaier, ¿¿¿Glucocorticoid use in prostate cancer and other solid tumours implications for effectiveness of cytotoxictreatment and...
|
|
Cite Document
2059 Exhibit: JSN 2059 Petrylak et al, ¿¿¿Docetaxel and Estramustine Compared wit...
Document
IPR2016-01582, No. 2059-138 Exhibit - JSN 2059 Petrylak et al, ¿¿¿Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer,¿¿¿ NEJM,...
|
|
Cite Document
1041 Exhibit: Remingtons Pharmaceutical Sciences 1980
Document
IPR2016-01582, No. 1041-40 Exhibit - Remingtons Pharmaceutical Sciences 1980 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
